MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2019-04-03 for NUCLEUS HYBRID L24 CI24RE (L24) N/A manufactured by Cochlear Ltd.
[140871969]
(b)(4).
Patient Sequence No: 1, Text Type: N, H10
[140871970]
Per the surgeon, the patient experienced poor performance with device use and subsequently the device was electively explanted on (b)(6) 2019. The patient was reimplanted with a new device during the same surgery.
Patient Sequence No: 1, Text Type: D, B5
Report Number | 6000034-2019-00495 |
MDR Report Key | 8481164 |
Report Source | HEALTH PROFESSIONAL |
Date Received | 2019-04-03 |
Date of Report | 2019-04-16 |
Date Mfgr Received | 2019-04-16 |
Device Manufacturer Date | 2015-10-12 |
Date Added to Maude | 2019-04-03 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Manufacturer Contact | MS. KRISTEL KOHNE |
Manufacturer Street | 1 UNIVERSITY AVENUE |
Manufacturer City | MACQAURIE UNIVERSITY, NSW 2109 |
Manufacturer Country | AS |
Manufacturer Postal | 2109 |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 3 |
Brand Name | NUCLEUS HYBRID L24 |
Generic Name | NUCLEUS HYBRID COCHLEAR IMPLANT SYSTEM |
Product Code | PGQ |
Date Received | 2019-04-03 |
Returned To Mfg | 2019-03-19 |
Model Number | CI24RE (L24) |
Catalog Number | N/A |
Lot Number | N/A |
Device Expiration Date | 2017-10-11 |
Operator | LAY USER/PATIENT |
Device Availability | R |
Device Age | DA |
Device Eval'ed by Mfgr | Y |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | COCHLEAR LTD |
Manufacturer Address | 1 UNIVERSITY AVENUE MACQUARIE UNIVERSITY, NSW 2109 AS 2109 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Required No Informationntervention | 2019-04-03 |